News and Analysis

Monte Rosa Therapeutics scores $32.5m Series A

Boston-based Monte Rosa Therapeutics, a biotechnology company, has raised $32.5 million in Series A funding.

-

Boston-based Monte Rosa Therapeutics, a biotechnology company, has raised $32.5 million in Series A funding. The investors were Versant Ventures and New Enterprise Associates.

Source: Press Release